UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3278-3285

2011

Volltextzugriff (PDF)

Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1656-1662

2012

Volltextzugriff (PDF)

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3383-3388

2012

Volltextzugriff (PDF)

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5165-5169

2008

Volltextzugriff (PDF)

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148

Journal of clinical oncology, 2008-09, Vol.26 (26), p.4319-4325

2008

Volltextzugriff (PDF)

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

CA: a cancer journal for clinicians, 2017-11, Vol.67 (6), p.493-506

2017

Volltextzugriff (PDF)

Paclitaxel and Carboplatin, Alone or With Irradiation, in Advanced or Recurrent Endometrial Cancer: A Phase II Study

Journal of clinical oncology, 2001-10, Vol.19 (20), p.4048-4053

2001

Volltextzugriff (PDF)

Early-Stage Endometrioid Ovarian Carcinoma: Population-Based Outcomes in British Columbia

International journal of gynecological cancer, 2014-10, Vol.24 (8), p.1401-1405

2014

Volltextzugriff (PDF)

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations

Leukemia & lymphoma, 2005-07, Vol.46 (7), p.1085-1089

2005

Volltextzugriff (PDF)

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience

Gynecologic oncology, 2008-01, Vol.108 (1), p.58-62

2008

Volltextzugriff (PDF)

Single or two drug combination therapy as initial treatment for low risk, gestational trophoblastic neoplasia. A Canadian analysis

Gynecologic oncology, 2020-05, Vol.157 (2), p.367-371

2020

Volltextzugriff (PDF)

Time for a level playing field: inequalities in regulatory/approval processes—the example of bevacizumab in epithelial ovarian cancer

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1539-1542

2015

Volltextzugriff (PDF)

Preoperative Radiotherapy for Inoperable Stage II Endometrial Cancer: Insights into Improving Treatment and Outcomes

Journal of obstetrics and gynaecology Canada, 2013-07, Vol.35 (7), p.635-639

2013

Volltextzugriff (PDF)

Which is the better surgical strategy for newly diagnosed epithelial ovarian cancer: primary or interval debulking?

Current opinion in oncology, 2011-09, Vol.23 (5), p.501-506

Hoskins, Paul J

2011

Volltextzugriff (PDF)

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Blood advances, 2021-03, Vol.5 (5), p.1483-1489

2021

Volltextzugriff (PDF)

Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1355-1358

Hoskins, Paul J

2009

Volltextzugriff (PDF)

Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas

International journal of gynecological cancer, 2017-11, Vol.27 (9), p.1819-1825

2017

Volltextzugriff (PDF)

Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer—the British Columbia Cancer Agency experience

Gynecologic oncology, 2008-12, Vol.111 (3), p.474-477

2008

Volltextzugriff (PDF)

The role of the fallopian tube in ovarian cancer

Clinical advances in hematology & oncology, 2012-05, Vol.10 (5), p.296-306

2012

Volltextzugriff (PDF)

Identifying patients unlikely to benefit from further chemotherapy: A descriptive study of outcome at each relapse in ovarian cancer

Gynecologic oncology, 2005-06, Vol.97 (3), p.862-869

2005

Volltextzugriff (PDF)

Controversies in the Management of Endometrial Cancer

Obstetrics and gynecology international, 2010-01, Vol.2010 (1)

2010

Volltextzugriff (PDF)

Molecular Profiling of Endometrial Malignancies

Obstetrics and gynecology international, 2010-01, Vol.2010 (1), p.162363-162363

2010

Volltextzugriff (PDF)

Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma

Journal of clinical oncology, 2006-05, Vol.24 (15), p.2388-2389

2006

Volltextzugriff (PDF)

Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?

Obstetrics and gynecology international, 2010-01, Vol.2010 (1), p.749579

2010

Volltextzugriff (PDF)

Small-Cell Carcinoma of the Cervix: Fourteen Years of Experience at a Single Institution Using a Combined-Modality Regimen of Involved-Field Irradiation and Platinum-Based Combination Chemotherapy

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3495-3501

2003

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(170)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(199)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(139)
Life Sciences & Biomedicine
(113)
Humans
(91)
Female
(71)
Oncology
(55)
Middle Aged
(50)
Biological And Medical Sciences
(48)
Aged
(47)
Medical Sciences
(45)
Adult
(40)
Male
(34)
Obstetrics & Gynecology
(32)
Tumors
(27)
Physical Sciences
(22)
Neoplasm Staging
(21)
Aged, 80 And Over
(19)
Chemotherapy
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Gynecology. Andrology. Obstetrics
(18)
Female Genital Diseases
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Paclitaxel and Carboplatin, Alone or With Irradiation, in Advanced or Recurrent Endometrial Cancer: A Phase II Study

Early-Stage Endometrioid Ovarian Carcinoma: Population-Based Outcomes in British Columbia

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience

Single or two drug combination therapy as initial treatment for low risk, gestational trophoblastic neoplasia. A Canadian analysis

Time for a level playing field: inequalities in regulatory/approval processes—the example of bevacizumab in epithelial ovarian cancer

Preoperative Radiotherapy for Inoperable Stage II Endometrial Cancer: Insights into Improving Treatment and Outcomes

Which is the better surgical strategy for newly diagnosed epithelial ovarian cancer: primary or interval debulking?

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Triple cytotoxic therapy for advanced ovarian cancer: a failed application, not a failed strategy

Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas

Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer—the British Columbia Cancer Agency experience

The role of the fallopian tube in ovarian cancer

Identifying patients unlikely to benefit from further chemotherapy: A descriptive study of outcome at each relapse in ovarian cancer

Controversies in the Management of Endometrial Cancer

Molecular Profiling of Endometrial Malignancies

Paraneoplastic erythropoietin-induced polycythemia associated with small lymphocytic lymphoma

Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?

Small-Cell Carcinoma of the Cervix: Fourteen Years of Experience at a Single Institution Using a Combined-Modality Regimen of Involved-Field Irradiation and Platinum-Based Combination Chemotherapy

Suchergebnisse filtern